caIL-12IL-12checkpoint inhibitorsInvasive bladder cancerNational Cancer InstituteNC State Universityinvasive urothelial carcinomaAbstractinvasive urothelial carcinomaimmunotherapyU01CA272258
… responses to intravesical CS/IL-12.Conclusions Intravesical CS/caIL-12 treatments have been generally well-tolerated. Five dose levels…